Tudóstér: Tóth Attila publikációi

Enyedi, E., Petukhov, P., Kozuch, A., Dudek, S., Tóth, A., Fagyas, M., Danilov, S.: ACE Phenotyping in Human Blood and Tissues: revelation of ACE Outliers and Sex Differences in ACE Sialylation.
Biomedicines. 12 (5), 1-17, 2024.

Tóth, E., Fagyas, M., Nagy, B., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
GeroScience. 46 (2), 1561-1574, 2024.

Szabó, A., Enyedi, E., Altorjay, I., Hajnal, P., Pintér, T., Mányiné Siket, I., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Get reliable laboratory findings: how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?.
Clin. Chem. Lab. Med. 62 (7), 1393-1401, 2024.

Abdisa, K., Szerdahelyi, E., Molnár, M., Friedrich, L., Lakner, Z., Koris, A., Tóth, A., Nath, A.: Metabolic Syndrome and Biotherapeutic Activity of Dairy (Cow and Buffalo) Milk Proteins and Peptides: fast Food-Induced Obesity Perspective - A Narrative Review.
Biomolecules. 14 (4), 1-61, 2024.

Kovács, Á., Zhazykbayeva, S., Herwig, M., Fülöp, G., Csípő, T., Oláh, N., Hassoun, R., Budde, H., Osman, H., Kaçmaz, M., Jaquet, K., Priksz, D., Juhász, B., Akin, I., Papp, Z., Schmidt, W., Mügge, A., El-Battrawy, I., Tóth, A., Hamdani, N.: Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats.
GeroScience. [Epub ahead of print]2024.

Papp, H., Tóth, E., Bóvári-Biri, J., Bánfai, K., Juhász, P., Mahdi, M., Russo, L., Bajusz, D., Sipos, A., Petri, L., Szalai, T., Kemény, Á., Madai, M., Kuczmog, A., Batta, G., Mózner, O., Vaskó, D., Hirsch, E., Bohus, P., Méhes, G., Tőzsér, J., Curtin, N., Helyes, Z., Tóth, A., Hoch, N., Jakab, F., Keserű, G., Pongrácz, J., Bai, P.: The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
Br. J. Pharmacol. 181 (23), 4782-4803, 2024.

Tóth, A., Pórszász, R., Phan, T., Ahern, G.: TRPV1 in blood pressure regulation: a new therapeutic target in hypertension?.
In: TRP channels as therapeutic targets : Advances in basic science and clinical use (2. edition). Ed.: Arpad Szallasi, Elsevier, Cambridge, 343-354, 2024. ISBN: 9780443186530

Berkowicz, P., Totoń-Żurańska, J., Kwiatkowski, G., Jasztal, A., Csípő, T., Kus, K., Tyrankiewicz, U., Orzyłowska, A., Wołkow, P., Tóth, A., Chlopicki, S.: Accelerated ageing and coronary microvascular dysfunction in chronic heart failure in Tgαq*44 mice.
GeroScience. 45 (3), 1619-1648, 2023.

Ráduly, A., Sárkány, F., Kovács, M., Juhász, B., Horváth, B., Szentandrássy, N., Nánási, P., Édes, I., Csanádi, Z., Tóth, A., Papp, Z., Priksz, D., Borbély, A.: A kardiális miozinaktivátorok klinikai alkalmazhatósága a preklinikai vizsgálatok tükrében.
Cardiol. Hung. 53 (5), 476-483, 2023.

Bernát, B., Erdélyi, R., Fazekas, L., Garami, G., Szekeres, R., Takács, B., Bombicz, M., Varga, B., Sárkány, F., Ráduly, A., Romanescu, D., Papp, Z., Tóth, A., Szilvássy, Z., Juhász, B., Priksz, D.: Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats.
Pharmaceuticals (Basel). 16 (3), 1-22, 2023.

Szuromi, L., Hajas, O., Nagy-Baló, E., Forgács, I., Nagy, L., Fagyas, M., Tóth, A., Nagy, B., Kappelmayer, J., Csanádi, Z.: Long-Term Changes in the Biomarkers of Left Atrial Fibrosis after Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation.
Rev. Cardiovasc. Med. 24 (6), 171, 2023.

Papp, Z., Sárkány, F., Ráduly, A., Pásztor, D., Máté, B., Tóth, A., Borbély, A.: Mi az eredményesebb stratégia: a miozin aktivációja vagy gátlása?.
Cardiol. Hung. 53 (4), 331-336, 2023.

Ráduly, A., Tóth, A., Sárkány, F., Horváth, B., Szentandrássy, N., Nánási, P., Csanádi, Z., Édes, I., Papp, Z., Borbély, A.: Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.
ESC Heart Failure. 10 (2), 1326-1335, 2023.

Zhazykbayeva, S., Hassoun, R., Herwig, M., Budde, H., Kovács, Á., Mannherz, H., El-Battrawy, I., Tóth, A., Schmidt, W., Mügge, A., Hamdani, N.: Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats.
Front. Cardiovasc. Med. 10 1-14, 2023.

Ráduly, A., Sárkány, F., Kovács, M., Bernát, B., Juhász, B., Szilvássy, Z., Pórszász, R., Horváth, B., Szentandrássy, N., Nánási, P., Csanádi, Z., Édes, I., Tóth, A., Papp, Z., Priksz, D., Borbély, A.: The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications.
Int. J. Mol. Sci. 24 (1), 446, 2023.

Kozuch, A., Petukhov, P., Fagyas, M., Popova, I., Lindeblad, M., Bobkov, A., Kamalov, A., Tóth, A., Dudek, S., Danilov, S.: Urinary ACE Phenotyping as a Research and Diagnostic Tool: Identification of Sex-Dependent ACE Immunoreactivity.
Biomedicines. 11 (3), 1-19, 2023.

Csípő, T., Czikora, Á., Fülöp, G., Gulyás, H., Rutkai, I., Pásztorné Tóth, E., Pórszász, R., Szalai, A., Bölcskei, K., Helyes, Z., Pintér, E., Papp, Z., Ungvári, Z., Tóth, A.: A Central Role for TRPM4 in Ca2+-Signal Amplification and Vasoconstriction.
Int. J. Mol. Sci. 23 (3), 1-13, 2022.

Nyúl-Tóth, Á., Fülöp, G., Tarantini, S., Kiss, T., Ahire, C., Faakye, J., Ungvári, A., Tóth, P., Tóth, A., Csiszár, A., Ungvári, Z.: Cerebral venous congestion exacerbates cerebral microhemorrhages in mice.
GeroScience. 44 (2), 805-816, 2022.

Fagyas, M., Fejes, Z., Sütő, R., Nagy, Z., Székely, B., Pócsi, M., Ivády, G., Bíró, E., Bekő, G., Nagy, A., Kerekes, G., Szentkereszty, Z., Papp, Z., Tóth, A., Kappelmayer, J., Nagy, B.: Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.
Int. J. Infect. Dis. 115 8-16, 2022.

Nath, A., Ahmad, A., Amankwaa, A., Csehi, B., Mednyánszky, Z., Szerdahelyi, E., Tóth, A., Tormási, J., Truong, D., Abrankó, L., Koris, A.: Hydrolysis of Soybean Milk Protein by Papain: antioxidant, Anti-Angiotensin, Antigenic and Digestibility Perspectives.
Bioengineering. 9 (9), 1-21, 2022.

Nagy, L., Rauch, B., Szerafin, T., Uray, K., Tóth, A., Bai, P.: Nicotinamide-riboside shifts the differentiation of human primary white adipocytes to beige adipocytes impacting substrate preference and uncoupling respiration through SIRT1 activation and mitochondria-derived reactive species production.
Front. Cell. Dev. Biol. 10 1-12, 2022.

Priksz, D., Lampé, N., Kovács, Á., Herwig, M., Bombicz, M., Varga, B., Wilisicz, T., Szilvássy, J., Pósa, A., Kiss, R., Gesztelyi, R., Ráduly, A., Szekeres, R., Sieme, M., Papp, Z., Tóth, A., Hamdani, N., Szilvássy, Z., Juhász, B.: Nicotinic-acid derivative BGP-15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy.
Br. J. Pharmacol. 179 (10), 2240-2258, 2022.

Tangos, M., Budde, H., Kolijn, D., Sieme, M., Zhazykbayeva, S., Lódi, M., Herwig, M., Gömöri, K., Hassoun, R., Robinson, E., Meister, T., Jaquet, K., Kovács, Á., Mustroph, J., Evert, K., Babel, N., Fagyas, M., Lindner, D., Püschel, K., Westermann, D., Mannherz, H., Paneni, F., Pfaender, S., Tóth, A., Mügge, A., Sossalla, S., Hamdani, N.: SARS-CoV-2 infects human cardiac myocytes promoted by inflammation and oxidative stress.
Int. J. Cardiol. 362 196-205, 2022.

Fagyas, M., Nagy, B., Ráduly, A., Mányiné Siket, I., Mártha, L., Erdősi, G., Sipka, S., Enyedi, E., Szabó, A., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bai, P., Bácsi, A., Tóth, A.: The majority of severe COVID-19 patients develop anti-cardiac autoantibodies.
GeroScience. 44 2347-2360, 2022.

Phan, T., Ton, H., Gulyás, H., Pórszász, R., Tóth, A., Russo, R., Kay, M., Sahibzada, N., Ahern, G.: TRPV1 in arteries enables a rapid myogenic tone.
J. Physiol.-London. 600 (7), 1651-1666, 2022.

Nagy, B., Fejes, Z., Szentkereszty, Z., Sütő, R., Várkonyi, I., Ajzner, É., Kappelmayer, J., Papp, Z., Tóth, A., Fagyas, M.: A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
Int. J. Infect. Dis. 103 412-414, 2021.

Bódi, B., Pilz, P., Mártha, L., Lang, M., Hamza, O., Fagyas, M., Szabó, P., Abraham, D., Tóth, A., Podesser, B., Kiss, A., Papp, Z.: Alterations in ACE and ACE2 Activities and Cardiomyocyte Signaling Underlie Improved Myocardial Function in a Rat Model of Repeated Remote Ischemic Conditioning.
Int. J. Mol. Sci. 22 (20), 1-17, 2021.

Nath, A., Csighy, A., Burak, A., Tjandra Nugraha, D., Pásztorné-Huszár, K., Tóth, A., Takács, K., Szerdahelyi, E., Kiskó, G., Kovács, Z., Koris, A., Vatai, G.: Bioactive Peptides from Liquid Milk Protein Concentrate by Sequential Tryptic and Microbial Hydrolysis.
Processes. 9 (10), 1-31, 2021.

Fagyas, M., Bánhegyi, V., Úri, K., Enyedi, A., Lizanecz, E., Mányiné Siket, I., Mártha, L., Fülöp, G., Radovits, T., Pólos, M., Merkely, B., Kovács, Á., Szilvássy, Z., Ungvári, Z., Édes, I., Csanádi, Z., Boczán, J., Takács, I., Szabó, G., Balla, J., Balla, G., Seferović, P., Papp, Z., Tóth, A.: Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.
GeroScience. 43 (5), 2289-2304, 2021.

Csongrádi, A., Altorjay, I., Fülöp, G., Enyedi, A., Enyedi, E., Hajnal, P., Takács, I., Tóth, A., Papp, Z., Fagyas, M.: Chitotriosidase gene polymorphisms and mutations limit the determination of chitotriosidase expression in sarcoidosis.
Clin. Chim. Acta. 513 50-56, 2021.

Bódi, B., Oláh, A., Mártha, L., Tóth, A., Radovits, T., Merkely, B., Papp, Z.: Exercise-induced alterations of myocardial sarcomere dynamics are associated with hypophosphorylation of cardiac troponin I.
Reviews in Cardiovascular Medicine. 22 (4), 1079-1085, 2021.

Bánhegyi, V., Enyedi, A., Fülöp, G., Oláh, A., Mányiné Siket, I., Váradi, C., Bottyán, K., Lódi, M., Csongrádi, A., Umar, M., Fagyas, M., Czuriga, D., Édes, I., Pólos, M., Merkely, B., Csanádi, Z., Papp, Z., Szabó, G., Radovits, T., Takács, I., Tóth, A.: Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart.
Cells. 10 (7), 1-13, 2021.

Kovács, Á., Herwig, M., Budde, H., Delalat, S., Kolijn, D., Bódi, B., Hassoun, R., Tangos, M., Zhazykbayeva, S., Balogh, Á., Czuriga, D., Linthout, S., Tschöpe, C., Dhalla, N., Mügge, A., Tóth, A., Papp, Z., Barta, J., Hamdani, N.: Interventricular Differences of Signaling Pathways-Mediated Regulation of Cardiomyocyte Function in Response to High Oxidative Stress in the Post-Ischemic Failing Rat Heart.
Antioxidants. 10 (6), 1-21, 2021.

Fagyas, M., Kertész, A., Mányiné Siket, I., Bánhegyi, V., Kracskó, B., Szegedi, A., Szokol, M., Vajda, G., Rácz, I., Gulyás, H., Szkibák, N., Rácz, V., Csanádi, Z., Papp, Z., Tóth, A., Sipka, S.: Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19.
GeroScience. 43 (1), 19-29, 2021.

Bódi, B., Kovács, Á., Gulyás, H., Mártha, L., Tóth, A., Mátyás, C., Barta, B., Oláh, A., Merkely, B., Radovits, T., Papp, Z.: Long-Term PDE-5A Inhibition Improves Myofilament Function in Left and Right Ventricular Cardiomyocytes through Partially Different Mechanisms in Diabetic Rat Hearts.
Antioxidants. 10 (11), 1-13, 2021.

Fülöp, G., Oláh, A., Csípő, T., Kovács, Á., Pórszász, R., Veress, R., Horváth, B., Nagy, L., Bódi, B., Fagyas, M., Helgadottir, S., Bánhegyi, V., Juhász, B., Bombicz, M., Priksz, D., Nánási, P., Merkely, B., Édes, I., Csanádi, Z., Papp, Z., Radovits, T., Tóth, A.: Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans.
Basic Res. Cardiol. 116 (1), 24, 2021.

Ráduly, A., Tóth, A., Papp, Z., Borbély, A.: Új lehetőség a szisztolés szívelégtelenség (HFrEF) kezelésében: omecamtiv-mecarbil.
Cardiol. Hung. 51 (2), 118-124, 2021.

Sipka, S., Tóth, A., Sipka, S.: A felületaktivált XII-es véralvadási faktor életkortól függő lehetséges szerepe a "bradikininvihar" kialakításában COVID-19-betegekben.
Orv. hetil. 161 (50), 2099-2103, 2020.

Enyedi, A., Csongrádi, A., Altorjay, I., Beke, G., Váradi, C., Enyedi, E., Kiss, D., Bányai, E., Kalina, E., Kappelmayer, J., Tóth, A., Papp, Z., Takács, I., Fagyas, M.: Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis.
Clin. Chim. Acta. 500 155-162, 2020.

Nagy, L., Béke, F., Juhász, L., Kovács, T., Juhász-Tóth, É., Docsa, T., Tóth, A., Gergely, P., Somsák, L., Bai, P.: Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.
PLoS One. 15 (9), 1-15, 2020.

Alvarado, G., Tóth, A., Csősz, É., Kalló, G., Dankó, K., Csernátony, Z., Smith, A., Gram, M., Akerström, B., Édes, I., Balla, G., Papp, Z., Balla, J.: Heme-Induced Oxidation of Cysteine Groups of Myofilament Proteins Leads to Contractile Dysfunction of Permeabilized Human Skeletal Muscle Fibres.
Int. J. Mol. Sci. 21 (21), 1-17, 2020.

Papp, Z., Tóth, A.: New treatment options to reduce heart failure hospitalization.
ESC Heart Failure. 7 (6), 3271-3273, 2020.

Nath, A., Burak, A., Csighy, A., Pásztorné-Huszár, K., Kiskó, G., Abrankó, L., Tóth, A., Szerdahelyi, E., Kovács, Z., Koris, A., Vatai, G.: Production of Liquid Milk Protein Concentrate with Antioxidant Capacity, Angiotensin Converting Enzyme Inhibitory Activity, Antibacterial Activity, and Hypoallergenic Property by Membrane Filtration and Enzymatic Modification of Proteins.
Processes. 8 (7), 1-25, 2020.

Lódi, M., Bánhegyi, V., Bódi, B., Gyöngyösi, A., Kovács, Á., Árokszállási, A., Hamdani, N., Fagyas, M., Édes, I., Csanádi, Z., Czuriga, I., Kisvárday, Z., Lekli, I., Bai, P., Tóth, A., Papp, Z., Czuriga, D.: Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 18 (1), 470, 2020.

Santer, D., Nagel, F., Gonçalves, I., Kaun, C., Wojta, J., Fagyas, M., Krššák, M., Balogh, Á., Papp, Z., Tóth, A., Bánhegyi, V., Trescher, K., Kiss, A., Podesser, B.: Tenascin-C aggravates ventricular dilatation and angiotensin-converting enzyme activity after myocardial infarction in mice.
ESC Heart Failure. 7 (5), 2113-2122, 2020.

Phan, T., Ton, H., Gulyás, H., Pórszász, R., Tóth, A., Russo, R., Kay, M., Niaz, S., Ahern, G.: TRPV1 expressed throughout the arterial circulation regulates vasoconstriction and blood pressure.
J. Physiol. 598 (24), 5639-5659, 2020.

Lódi, M., Priksz, D., Fülöp, G., Bódi, B., Gyöngyösi, A., Nagy, L., Kovács, Á., Kertész, A., Kocsis, J., Édes, I., Csanádi, Z., Czuriga, I., Kisvárday, Z., Juhász, B., Lekli, I., Bai, P., Tóth, A., Papp, Z., Czuriga, D.: Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 17 229, 2019.

Bánhegyi, V., Mányiné Siket, I., Bottyán, K., Bácsi, A., Hajas, G., Papp, Z., Tóth, A.: Angiotenzin konvertáló enzimek szekréciós mechanizmusának vizsgálata.
Cardiol. Hung. 49 (Supplementum), B22-B23, 2019.

Fülöp, G., Ahire, C., Csípő, T., Tarantini, S., Kiss, T., Balasubramanian, P., Yabluchanskiy, A., Farkas, E., Tóth, A., Nyúl-Tóth, Á., Tóth, P., Csiszár, A., Ungvári, Z.: Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice.
GeroScience. 41 (5), 575-589, 2019.

Tóth, A., Fagyas, M., Papp, Z., Édes, I.: Dilution based inhibition assay.
[szabadalom]

Nagy, L., Rauch, B., Balla, N., Ujlaki, G., Kis, G., Omar, A., Kristóf, E., Sipos, A., Antal, M., Tóth, A., Debreceni, T., Horváth, A., Maros, T., Csizmadia, P., Szerafin, T., Bai, P.: Olaparib induces browning of in vitro cultures of human primary white adipocytes.
Biochem. Pharmacol. 167 76-85, 2019.

Bombicz, M., Priksz, D., Gesztelyi, R., Kiss, R., Hollós, N., Varga, B., Németh, J., Tóth, A., Papp, Z., Szilvássy, Z., Juhász, B.: The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy.
Molecules. 24 (3), 1-18, 2019.

Tarantini, S., Yabluchanskiy, A., Csípő, T., Fülöp, G., Kiss, T., Balasubramanian, P., DelFavero, J., Ahire, C., Ungvári, A., Nyúl-Tóth, Á., Farkas, E., Benyó, Z., Tóth, A., Csiszár, A., Ungvári, Z.: Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging.
GeroScience. 41 (5), 533-542, 2019.

Bai, P., Nagy, L., Abdul-Rahman, O., Rauch, B., Balla, N., Kristóf, E., Tóth, A., Szerafin, T.: NAD+ homeostasis plays role in mitochondrial biogenesis during beige adipocyte differentiation.
Biochim. Biophys. Acta. Bioenerg. 1859 e36, 2018.

Csongrádi, A., Enyedi, A., Takács, I., Végh, T., Mányiné Siket, I., Pólik, Z., Altorjay, I., Balla, J., Balla, G., Édes, I., Kappelmayer, J., Tóth, A., Papp, Z., Fagyas, M.: Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis.
Clin. Chem. Lab. Med. 56 (7), 1117-1125, 2018.

Priksz, D., Bombicz, M., Varga, B., Kurucz, A., Gesztelyi, R., Balla, J., Tóth, A., Papp, Z., Szilvássy, Z., Juhász, B.: Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease.
Int. J. Mol. Sci. 19 (10), 1-18, 2018.

Csongrádi, A., Mányiné Siket, I., Csípő, T., Tóth, A., Papp, Z., Szerafin, T., Fagyas, M.: A hemoglobin és bomlástermékei gátolják a szérum- és a szöveti ACE-aktivitást.
Cardiol. Hung. 47 (Suppl.), C36, 2017.

Horváth, B., Szentandrássy, N., Veress, R., Almássy, J., Magyar, J., Bányász, T., Tóth, A., Papp, Z., Nánási, P.: Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.
Naunyn Schmiedebergs Arch. Pharmacol. 390 (2), 1239-1246, 2017.

Cséplő, P., Vámos, Z., Török, O., Ivic, I., Tóth, A., Buki, A., Koller, Á.: Hemolyzed Blood Elicits a Calcium Antagonist and High CO2 Reversible Constriction via Elevation of [Ca2+] in Isolated Cerebral Arteries.
J. Neurotrauma. 34 (2), 529-534, 2017.

Szokol, M., Priksz, D., Bombicz, M., Varga, B., Kovács, Á., Fülöp, G., Csípő, T., Pósa, A., Tóth, A., Papp, Z., Szilvássy, Z., Juhász, B.: Long term osmotic mini pump treatment with alpha-MSH improves myocardial function in Zucker Diabetic Fatty rats.
Molecules. 22 (10), 1-18, 2017.

Kovács, Á., Kalász, J., Pásztorné Tóth, E., Tóth, A., Papp, Z., Dhalla, N., Barta, J.: Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca2+-paradox rat hearts.
Mol. Cell. Biochem. 403 (1-2), 57-68, 2017.

Fagyas, M., Altorjay, I., Csongrádi, A., Enyedi, A., Takács, I., Papp, Z., Tóth, A.: Optimized ACE-activity assay for the accurate diagnosis of sarcoidosis.
Clin. Chem. Lab. Med. 55 (Special), S235, 2017.

Fagyas, M., Csongrádi, A., Mányiné Siket, I., Papp, Z., Tóth, A.: Szabad zsírsavak szerepe az endogén ACE-gátlás kialakításában.
Cardiol. Hung. 47 (Suppl.), C37, 2017.

Bódi, B., Pásztorné Tóth, E., Nagy, L., Tóth, A., Mártha, L., Kovács, Á., Balla, G., Kovács, T., Papp, Z.: Titin isoforms are increasingly protected against oxidative modifications in developing rat cardiomyocytes.
Free Radic. Biol. Med. 113 224-235, 2017.

Abdul-Rahman, O., Kristóf, E., Doan-Xuan, Q., Vida, A., Nagy, L., Horváth, A., Simon, J., Maros, T., Szentkirályi, I., Palotás, L., Debreceni, T., Csizmadia, P., Szerafin, T., Fodor, T., Szántó, M., Tóth, A., Kiss, B., Bacsó, Z., Bai, P.: AMP-Activated Kinase (AMPK) Activation by AICAR in Human White Adipocytes Derived from Pericardial White Adipose Tissue Stem Cells Induces a Partial Beige-Like Phenotype.
PLoS One. 11 (6), e0157644, 2016.

Fedor, R., Kovács, D., Lőcsey, L., Fagyas, M., Asztalos, L., Tóth, A.: Az angiotenzinkonvertálóenzim-gén I/D polimorfizmusának hatása a vesetranszplantált betegek cardiovascularis rizikójára és a grafttúlélésre.
Orvosi Hetilap. 157 (24), 938-945, 2016.

Úri, K., Fagyas, M., Kertész, A., Borbély, A., Jenei, C., Bene, O., Csanádi, Z., Paulus, W., Édes, I., Papp, Z., Tóth, A., Lizanecz, E.: Circulating ACE2 activity correlates with cardiovascular disease development.
J. Renin-Angio-Aldo S. 17 (4), 1-11, 2016.

Csongrádi, A., Tóth, A., Mányiné Siket, I., Papp, Z., Fagyas, M.: Hemoglobin and it's degradation products inhibit ACE-activity.
Current Res. Cardiol. 3 (3), 106, 2016.

Nagy, L., Pollesello, P., Haikala, H., Végh, Á., Sorsa, T., Levijoki, J., Szilágyi, S., Édes, I., Tóth, A., Papp, Z., Papp, G.: ORM-3819 promotes cardiac contractility through Ca2+ sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.
Eur. J. Pharmacol. 775 120-129, 2016.

Kovács, Á., Fülöp, G., Kovács, A., Csípő, T., Bódi, B., Priksz, D., Juhász, B., Beke, L., Hendrik, Z., Méhes, G., Granzier, H., Édes, I., Fagyas, M., Papp, Z., Barta, J., Tóth, A.: Renin overexpression leads to increased titin-based stiffness contributing to diastolic dysfunction in hypertensive mRen2 rats.
Am. J. Physiol.-Heart Circul. Physiol. 310 (11), H1671-H1682, 2016.

Cséplő, P., Vámos, Z., Ivic, I., Török, O., Tóth, A., Koller, Á.: The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
PLoS One. 11 1-22, 2016.

Fekete, I., Varga, C., Biró, B., Tóth, A., Várbíró, G., Lajtha, K., Szabó, G., Kotroczó, Z.: The effects of litter production and litter depth on soil microclimate in a central european deciduous forest.
Plant Soil. 398 (1-2), 291-300, 2016.

Alvarado, G., Jeney, V., Tóth, A., Csősz, É., Kalló, G., Huynh, A., Hajnal, C., Kalász, J., Pásztorné Tóth, E., Édes, I., Gram, M., Akerström, B., Smith, A., Eaton, J., Balla, G., Papp, Z., Balla, J.: Heme-induced contractile dysfunction in Human cardiomyocytes caused by oxidant damage to thick filament proteins.
Free Radic. Biol. Med. 89 248-262, 2015.

Csató, V., Pető, A., Fülöp, G., Rutkai, I., Pásztorné Tóth, E., Fagyas, M., Kalász, J., Édes, I., Tóth, A., Papp, Z.: Myeloperoxidase evokes substantial vasomotor responses in isolated skeletal muscle arterioles of the rat.
Acta Physiol. 214 (1), 109-123, 2015.

Kalász, J., Pásztorné Tóth, E., Fagyas, M., Balogh, Á., Tóth, A., Csató, V., Édes, I., Papp, Z., Borbély, A.: Myeloperoxidase impairs the contractile function in isolated human cardiomyocytes.
Free Radic. Biol. Med. 84 116-127, 2015.

Nagy, L., Kovács, Á., Bódi, B., Pásztorné Tóth, E., Fülöp, G., Tóth, A., Édes, I., Papp, Z.: The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.
Br. J. Pharmacol. 172 (18), 4506-4518, 2015.

Csató, V., Pető, A., Koller, Á., Édes, I., Tóth, A., Papp, Z.: Hydrogen peroxide elicits constriction of skeletal muscle arterioles by activating the arachidonic acid pathway.
PLoS One. 9 (8), 1-10, 2014.

Balogh, Á., Tóth, A., Pásztorné Tóth, E., Nagy, L., Kovács, Á., Kalász, J., Contreras, G., Édes, I., Papp, Z.: Myofilament carbonylation modulates contractility in human cardiomyocytes.
Exp. Clin. Cardiol. 20 (1), 2026-2035, 2014.

Balogh, Á., Santer, D., Pásztorné Tóth, E., Tóth, A., Czuriga, D., Podesser, B., Trescher, K., Jaquet, K., Erdődi, F., Édes, I., Papp, Z.: Myofilament protein carbonylation contributes to the contractile dysfunction in the infarcted LV region of mouse hearts.
Cardiovasc. Res. 101 (1), 108-119, 2014.

Fagyas, M., Úri, K., Mányiné Siket, I., Daragó, A., Boczán, J., Bányai, E., Édes, I., Papp, Z., Tóth, A.: New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
PLoS One. 9 (4), 1-29, 2014.

Fagyas, M., Úri, K., Mányiné Siket, I., Fülöp, G., Csató, V., Daragó, A., Boczán, J., Bányai, E., Szentkirályi, I., Maros, T., Szerafin, T., Édes, I., Papp, Z., Tóth, A.: New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
PLoS One. 9 (4), 1-28, 2014.

Fagyas, M., Úri, K., Mányiné Siket, I., Daragó, A., Boczán, J., Bányai, E., Édes, I., Papp, Z., Tóth, A.: New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.
PLoS One. 9 (4), 1-29, 2014.

Úri, K., Fagyas, M., Mányiné Siket, I., Kertész, A., Csanádi, Z., Sándorfi, G., Clemens, M., Fedor, R., Papp, Z., Édes, I., Tóth, A., Lizanecz, E.: New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.
PLoS One. 9 (4), 1-32, 2014.

Kalász, J., Pásztorné Tóth, E., Bódi, B., Fagyas, M., Tóth, A., Bhattoa, H., Vári, S., Balog, M., Blažetić, S., Heffer, M., Papp, Z., Borbély, A.: Single acute stress-induced progesterone and ovariectomy alter cardiomyocyte contractile function in female rats.
Croat. Med. J. 55 (3), 239-249, 2014.

Tóth, A., Czikora, Á., Pásztorné Tóth, E., Dienes, B., Bai, P., Csernoch, L., Rutkai, I., Csató, V., Mányiné Siket, I., Pórszász, R., Édes, I., Papp, Z., Boczán, J.: Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat.
J. Histochem. Cytochem. 62 (2), 129-144, 2014.

Czikora, Á., Rutkai, I., Pásztorné Tóth, E., Szalai, A., Pórszász, R., Boczán, J., Édes, I., Papp, Z., Tóth, A.: Different desensitization patterns for sensory and vascular TRPV1 populations in the rat: expression, localization and functional consequences.
PLoS One. 8 (11), 1-8, 2013.

Sun, W., Liu, K., Ryu, H., Kang, D., Kim, Y., Kim, M., Cho, Y., Bhondwe, R., Thorat, S., Kim, H., Pearce, L., Pavlyukovets, V., Tran, R., Morgan, M., Lázár, J., Ryder, C., Tóth, A., Blumberg, P., Lee, J.: 2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: structure-activity relationships in the B and C-regions.
Bioorg. Med. Chem. 20 (3), 1310-1318, 2012.

Kolozsvári, B., Bakó, É., Bécsi, B., Kiss, A., Czikora, Á., Tóth, A., Vámosi, G., Gergely, P., Erdődi, F.: Calcineurin regulates endothelial barrier function by interaction with and dephosphorylation of myosin phosphatase.
Cardiovasc. Res. 96 (3), 494-503, 2012.

Czuriga, D., Tóth, A., Pásztorné Tóth, E., Balogh, Á., Dóczy-Bodnár, A., Nizsalóczki, E., Lionetti, V., Recchia, F., Czuriga, I., Édes, I., Papp, Z.: Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacing-induced heart failure.
Basic Res. Cardiol. 107 (2), 1-13, 2012.

Daragó, A., Fagyas, M., Mányiné Siket, I., Facskó, A., Megyesi, Z., Kalász, J., Galajda, Z., Szerafin, T., Hársfalvi, J., Édes, I., Papp, Z., Tóth, A., Szentmiklósi, J.: Differences in Angiotensin Convertase Enzyme (ACE) Activity and Expression May Contribute to Shorter Event Free Period After Coronary Artery Bypass Graft Surgery.
Cardiovasc. Ther. 30 (3), 136-144, 2012.

Czikora, Á., Lizanecz, E., Bakó, P., Rutkai, I., Ruzsnavszky, F., Magyar, J., Pórszász, R., Kark, T., Facskó, A., Papp, Z., Édes, I., Tóth, A.: Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1.
Br. J. Pharmacol. 165 (6), 1801-1812, 2012.

Fürjes, G., Tóth, G., Peitl, B., Pórszász, R., Lelesz, B., Sári, R., Tóth, A., Szilvássy, Z., Németh, J.: Thrittene radioimmunoassay: description and application of a novel method.
J. Radioanal. Nucl. Chem. 292 (1), 113-118, 2012.

Czikora, Á., Lizanecz, E., Boczán, J., Daragó, A., Papp, Z., Édes, I., Tóth, A.: Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation.
Life Sci. 90 (11-12), 407-415, 2012.

Ait Mou, Y., Tóth, A., Cassan, C., Czuriga, D., de Tombe, P., Papp, Z., Lacampagne, A., Cazorla, O.: Beneficial effects of SR33805 in failing myocardium.
Cardiovasc. Res. 91 (3), 412-419, 2011.

Fedor, R., Asztalos, L., Lőcsey, L., Szabó, L., Mányiné Siket, I., Fagyas, M., Lizanecz, E., Tóth, A.: Insertion/deletion polymorphism of the angiotensin-converting enzyme predicts left ventricular hypertrophy after renal transplantation.
Transplant. Proc. 43 (4), 1259-1260, 2011.

Szántó, M., Rutkai, I., Hegedűs, C., Czikora, Á., Rózsahegyi, M., Kiss, B., Virág, L., Gergely, P., Tóth, A., Bai, P.: Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction.
Cardiovasc. Res. 92 (3), 430-438, 2011.

Fedor, R., Asztalos, L., Lőcsey, L., Szabó, L., Mányiné Siket, I., Fagyas, M., Lizanecz, E., Tóth, A.: Insertion/Deletion polymorphism of angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy.
Transplant. Proc. 42 (6), 2304-2308, 2010.

Boczán, J., Tóth, A., Blumberg, P.: Anandamide an endogenous cannabinoid.
Vitamins & Hormones. 81 (C), 389-419, 2009.

Lim, J., Jin, M., Ryu, H., Kang, D., Lee, J., Pearce, L., Tran, R., Tóth, A., Blumberg, P.: Conformationally constrained analogues of N'-(4-tert-butylbenzyl)-N-(4-methylsulfonylaminobenzyl)thiourea as TRPV1 antagonists.
Eur. J. Med. Chem. 44 (1), 322-331, 2009.

Choi, H., Choi, S., Lee, Y., Kang, D., Ryu, H., Maeng, H., Chung, S., Pavlyukovets, V., Pearce, L., Tóth, A., Tran, R., Wang, Y., Morgan, M., Blumberg, P., Lee, J.: Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists.
Bioorg. Med. Chem. 17 (2), 690-698, 2009.

Molnár, A., Borbély, A., Czuriga, D., Mányiné Siket, I., Szilágyi, S., Hertelendi, Z., Pásztorné Tóth, E., Balogh, Á., Galajda, Z., Szerafin, T., Jaquet, K., Papp, Z., Édes, I., Tóth, A.: Protein kinase C contributes to the maintenance of contractile force in human ventricular cardiomyocytes.
J. Biol. Chem. 284 (2), 1031-1039, 2009.

Hertelendi, Z., Tóth, A., Borbély, A., Galajda, Z., Édes, I., Tósaki, Á., Papp, Z.: The peroxynitrite evoked contractile depression can be partially reversed by antioxidants in human cardiomyocytes.
J. Cell. Mol. Med. 13 (8B), 2200-2209, 2009.

Pearce, L., Tóth, A., Ryu, H., Kang, D., Choi, H., Jin, M., Lee, J., Blumberg, P.: Differential modulation of agonist and antagonist structure activity relations for rat TRPV1 by cyclosporin A and other protein phosphatase inhibitors.
Naunyn Schmiedebergs Arch. Pharmacol. 377 (2), 149-157, 2008.

Hegedűs, É., Imre, L., Pataki, J., Lizanecz, E., Székvölgyi, L., Fazakas, F., Bacsó, Z., Tóth, A., Szabó, M., Seres, Z., Szabó, G.: Heteroduplex analysis using flow cytometric microbead assays to detect deletions, insertions, and single-strand lesions.
Cytometry A. 73 (3), 238-245, 2008.

Édes, I., Tóth, A., Csányi, G., Lomnicka, M., Chlopicki, S., Édes, I., Papp, Z.: Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44).
J. Mol. Cell. Cardiol. 45 (3), 363-372, 2008.

Hertelendi, Z., Tóth, A., Borbély, A., Galajda, Z., Velden, J., Stienen, G., Édes, I., Papp, Z.: Oxidation of myofilament protein sulfhydryl groups reduces the contractile force and its Ca2+ sensitivity in human cardiomyocytes.
Antioxid. Redox Signal. 10 (7), 1175-1184, 2008.

Ryu, H., Jin, M., Kim, S., Choi, H., Kang, S., Kang, D., Lee, J., Pearce, L., Pavlyukovets, V., Morgan, M., Tran, R., Tóth, A., Lundberg, D., Blumberg, P.: Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.
J. Med. Chem. 51 (1), 57-67, 2008.

Kark, T., Bagi, Z., Lizanecz, E., Pásztorné Tóth, E., Erdei, N., Czikora, Á., Papp, Z., Édes, I., Pórszász, R., Tóth, A.: Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1.
Mol. Pharmacol. 73 (5), 1405-1412, 2008.

Chung, J., Kim, S., Lim, J., Choi, H., Kang, S., Yoon, H., Ryu, H., Kang, D., Lee, J., Kang, B., Choi, S., Tóth, A., Pearce, L., Pavlyukovets, V., Lundberg, D., Blumberg, P.: Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists.
Bioorg. Med. Chem. 15 (18), 6043-6053, 2007.

Molnár, A., Tóth, A., Bagi, Z., Papp, Z., Édes, I., Vaszily, M., Galajda, Z., Papp, G., Varró, A., Szűts, V., Lacza, Z., Gerö, D., Szabó, C.: Activation of the Poly(ADP-Ribose) Polymerase Pathway in Human Heart Failure.
Mol. Med. 12 (7-8), 143-152, 2006.

Erdei, N., Tóth, A., Pásztorné Tóth, E., Papp, Z., Édes, I., Koller, Á., Bagi, Z.: High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion.
Am. J. Physiol.-Heart Circul. Physiol. 291 (5), H2107-H2115, 2006.

Lázár, J., Braun, D., Tóth, A., Wang, Y., Pearce, L., Pavlyukovets, V., Blumberg, P., Garfield, S., Wincovitch, S., Choi, H., Lee, J.: Kinetics of Penetration Influence the Apparent Potency of Vanilloids on TRPV1.
Mol. Pharmacol. 69 (4), 1166-1173, 2006.

Lizanecz, E., Pásztorné Tóth, E., Mohácsi, A., Papp, Z., Édes, I., Tóth, A.: Mistyping of Angiotensinogen M235T Alleles.
Hypertens Res. 29 (3), 197-201, 2006.

Lizanecz, E., Bagi, Z., Pásztorné Tóth, E., Papp, Z., Édes, I., Kedei, N., Blumberg, P., Tóth, A.: Phosphorylation-Dependent Desensitization by Anandamide of Vanilloid Receptor-1 (TRPV1) Function in Rat Skeletal Muscle Arterioles and in Chinese Hamster Ovary Cells Expressing TRPV1.
Mol. Pharmacol. 69 (3), 1015-1023, 2006.

Lee, J., Kang, S., Kil, M., Shin, M., Lim, J., Choi, H., Jin, M., Kim, S., Kim, S., Lee, Y., Min, K., Kim, Y., Ha, H., Tran, R., Welter, J., Wang, Y., Szabó, T., Pearce, L., Lundberg, D., Tóth, A., Pavlyukovets, V., Morgan, M., Blumberg, P.: Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.
Bioorg. Med. Chem. Lett. 15 (18), 4136-4142, 2005.

Lee, J., Jin, M., Kang, S., Kim, S., Lee, J., Shin, M., Hwang, J., Cho, S., Choi, Y., Choi, H., Kim, S., Suh, Y., Lee, Y., Kim, Y., Ha, H., Tóth, A., Pearce, L., Tran, R., Szabó, T., Welter, J., Lundberg, D., Wang, Y., Lázár, J., Pavlyukovets, V., Morgan, M., Blumberg, P.: Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
Bioorg. Med. Chem. Lett. 15 (18), 4143-4150, 2005.

Barta, J., Tóth, A., Édes, I., Vaszily, M., Papp, G., Varró, A., Papp, Z.: Calpain-1-sensitive myofibrillar proteins of the human myocardium.
Mol. Cell. Biochem. 278 (1-2), 1-8, 2005.

Tóth, A., Wang, Y., Kedei, N., Tran, R., Pearce, L., Kang, S., Jin, M., Choi, H., Lee, J., Blumberg, P.: Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1.
Life Sci. 76 (25), 2921-2932, 2005.

Tóth, A., Boczán, J., Kedei, N., Lizanecz, E., Bagi, Z., Papp, Z., Édes, I., Csiba, L., Blumberg, P.: Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain.
Mol. Brain Res. 135 (1-2), 162-168, 2005.

Borbély, A., Tóth, A., Édes, I., Virág, L., Papp, G., Varró, A., Paulus, W., Velden, J., Stienen, G., Papp, Z.: Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells.
Cardiovasc. Res. 67 (2), 225-233, 2005.

Bagi, Z., Erdei, N., Tóth, A., Li, W., Hintze, T., Koller, Á., Kaley, G.: Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins.
Arterioscler. Thromb. Vasc. Biol. 25 (8), 1610-1616, 2005.

Lee, J., Kang, S., Choi, H., Lee, J., Lim, J., Kil, M., Jin, M., Kim, K., Sung, J., Chung, S., Ha, H., Kim, Y., Pearce, L., Tran, R., Lundberg, D., Wang, Y., Tóth, A., Blumberg, P.: Analysis of structure-activity relationships for the 'B-region' of N-(3-acyloxy-2-benzylpropyl)-N(')-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: discovery of an N-hydroxythiourea analogue with potent analgesic activity.
Bioorg. Med. Chem. Lett. 14 (9), 2291-2297, 2004.

Lee, J., Kim, S., Lee, J., Kang, M., Kil, M., Choi, H., Jin, M., Wang, Y., Tóth, A., Pearce, L., Lundberg, D., Tran, R., Blumberg, P.: Analysis of structure-activity relationships with the N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea template for vanilloid receptor 1 antagonism.
Bioorg. Med. Chem. 12 (13), 3411-3420, 2004.

Kedei, N., Lundberg, D., Tóth, A., Welburn, P., Garfield, S., Blumberg, P.: Characterization of the interaction of ingenol 3-angelate with protein kinase C.
Cancer Res. 64 (9), 3243-3255, 2004.

Tóth, A., Blumberg, P., Chen, Z., Kozikowski, A.: Design of a High-Affinity Competitive Antagonist of the Vanilloid Receptor Selective for the Calcium Entry-Linked Receptor Population.
Mol. Pharmacol. 65 (2), 282-291, 2004.

Wang, Y., Kedei, N., Wang, M., Wang, Q., Huppler, A., Tóth, A., Tran, R., Blumberg, P.: Interaction between protein kinase Cmu and the vanilloid receptor type 1.
J. Biol. Chem. 279 (51), 53674-53682, 2004.

Gavva, N., Klionsky, L., Qu, Y., Shi, L., Tamir, R., Edenson, S., Zhang, T., Viswanadhan, V., Tóth, A., Pearce, L., Vanderah, T., Porreca, F., Blumberg, P., Lile, J., Sun, Y., Wild, K., Louis, J., Treanor, J.: Molecular determinants of vanilloid sensitivity in TRPV1.
J. Biol. Chem. 279 (19), 20283-20295, 2004.

Lee, J., Kang, S., Lim, J., Choi, H., Jin, M., Tóth, A., Pearce, L., Tran, R., Wang, Y., Szabó, T., Blumberg, P.: N-[4-(Methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the 'C-Region'.
Bioorg. Med. Chem. 12 (2), 371-385, 2004.

Brodie, C., Steinhart, R., Kazimirsky, G., Rubinfeld, H., Hyman, T., Ayres, J., Min Hur, G., Tóth, A., Yang, D., Garfield, S., Stone, J., Blumberg, P.: PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters.
Mol. Pharmacol. 66 (1), 76-84, 2004.

Lee, J., Kim, S., Park, S., Lim, J., Kim, J., Kang, M., Lee, J., Kang, S., Choi, H., Jin, M., Welter, J., Szabó, T., Tran, R., Pearce, L., Tóth, A., Blumberg, P.: Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding.
Bioorg. Med. Chem. 12 (5), 1055-1069, 2004.

Tóth, A., Kedei, N., Wang, Y., Blumberg, P.: Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat.
Life Sci. 73 (4), 487-498, 2003.

Barta, J., Tóth, A., Jaquet, K., Redlich, A., Édes, I., Papp, Z.: Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy.
Mol. Cell. Biochem. 251 (1-2), 83-88, 2003.

Wang, Y., Tóth, A., Tran, R., Szabó, T., Welter, J., Blumberg, P., Lee, J., Kang, S., Lim, J., Lee, J.: High-Affinity Partial Agonists of the Vanilloid Receptor.
Mol. Pharmacol. 64 (2), 325-333, 2003.

Lee, J., Lee, J., Kang, M., Shin, M., Kim, J., Kang, S., Lim, J., Choi, H., Suh, Y., Park, H., Oh, U., Kim, H., Park, Y., Ha, H., Kim, Y., Tóth, A., Wang, Y., Tran, R., Pearce, L., Lundberg, D., Blumberg, P.: N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor.
J. Med. Chem. 46 (14), 3116-3126, 2003.

Wang, Y., Szabó, T., Welter, J., Tóth, A., Tran, R., Lee, J., Kang, S., Suh, Y., Blumberg, P., Lee, J.: High Affinity Antagonists of the Vanilloid Receptor.
Mol. Pharmacol. 62 (4), 947-956, 2002.

Tóth, A., Kedei, N., Szabó, T., Wang, Y., Blumberg, P.: Thapsigargin binds to and inhibits the cloned vanilloid receptor-1.
Biochem. Biophys. Res. Commun. 293 (2), 777-782, 2002.

Tóth, A., Kiss, E., Walsh, M., Hartshorne, D., Gergely, P., Erdődi, F.: Phosphorylation of MYPT1 by protein kinase C attenuates interaction with PP1 catalytic subunit and the 20 kDa light chain of myosin.
FEBS Lett. 484 (2), 113-117, 2000.

Tóth, A., Kiss, E., Herberg, F., Hartshorne, D., Gergely, P., Erdődi, F.: Study of the subunit interactions in myosin phosphatase by surface plasmon resonance.
Eur. J. Biochem. 267 (6), 1687-1697, 2000.